[Form 4] Eastman Chemical Company Insider Trading Activity

Rhea-AI Filing Summary

Brett D. Begemann, a director of Eastman Chemical Company (EMN), reported a purchase of 1,500 shares of the issuer's common stock on 08/27/2025 at a reported price of $68.285 per share. After the transaction, Mr. Begemann beneficially owned 9,520 shares. The Form 4 was signed on behalf of Mr. Begemann by Mark D. Austin under power of attorney on 08/28/2025.

Positive

• Insider purchase disclosed: Brett D. Begemann acquired 1,500 shares on 08/27/2025 at $68.285 per share.
• Increased beneficial ownership: Post-transaction holdings reported as 9,520 shares.
• Clear, routine disclosure: Transaction reported on a Form 4 with signature executed by power of attorney (Mark D. Austin).

Negative

• No dispositions or derivative transactions reported in this filing.
• No additional context provided about intent, plans, or relative size of the holding versus total outstanding shares.

Insights

Corporate Governance Expert

TL;DR: A company director reported a voluntary open-market purchase of 1,500 EMN shares, modestly increasing his beneficial holding to 9,520 shares.

The filing shows a non-derivative acquisition coded "P" for a purchase on 08/27/2025 at $68.285 per share. This is a straightforward Section 16 transaction with no derivatives, dispositions, or plan-related checkboxes indicated. The signature block shows the Form 4 was executed by a power of attorney, which is a routine administrative detail. The disclosure is complete for the reported transaction and contains no additional corporate governance events.

Securities Analyst

TL;DR: Insider purchase reported; transaction details are explicit and limited to a single open-market buy increasing direct beneficial ownership.

The report lists a single non-derivative purchase (1,500 shares) at $68.285, yielding a post-transaction holding of 9,520 shares. No derivative positions or dispositions are reported, and there are no amendments or plan-related disclosures. This Form 4 contains only routine insider trading information without additional material financial data.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BEGEMANN BRETT D

(Last) (First) (Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2025		P		1,500	A	$68.285	9,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Brett D. Begemann	08/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Brett D. Begemann report on Form 4 for EMN?

He reported purchasing 1,500 shares of Eastman Chemical Company common stock on 08/27/2025 at $68.285 per share.

How many EMN shares does Brett D. Begemann beneficially own after the transaction?

9,520 shares are reported as beneficially owned following the 08/27/2025 purchase.

Was the Form 4 signed directly by the reporting person?

No. The Form 4 was signed by Mark D. Austin by power of attorney for Brett D. Begemann on 08/28/2025.

Does the filing show any derivative or plan-based trades for EMN?

No. The filing reports only a non-derivative purchase (code P); no derivatives or plan-related checkboxes are indicated.

What price was paid per share in the reported EMN transaction?

$68.285 per share for the 1,500-share purchase on 08/27/2025.